Tumor Target Size
Tumor Target Size - Related Videos
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
0 Views •
Cited by 17 •
2019
This protocol describes a detailed workflow for the generation and ex vivo characterization of oncolytic viruses for expression of immunomodulators, using measles viruses encoding bispecific T cell engagers as an example. Application and adaptation to other vector platforms and transgenes will accelerate the development of novel immunovirotherapeutics for clinical translation.
11:52
Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
0 Views •
Cited by 1 •
2013
This article details the procedures for optical imaging analysis of the tumor-targeted nanoparticle, HerDox. In particular, detailed use of the multimode imaging device for detecting tumor targeting and assessing tumor penetration is described here.
10:44
Production of Large Numbers of Size-controlled Tumor Spheroids Using Microwell Plates
0 Views •
Cited by 36 •
2013
We introduce a protocol for the generation of large numbers (thousands to hundreds of thousands) of uniform size- and composition-controlled tumor spheroids, using commercially available microwell plates.
03:36
Pretargeted Radioimmunotherapy: A Method for Targeted Delivery of Therapeutic Radionuclides to Tumors
0 Views •
2023
This video describes the technique of pretargeted radioimmunotherapy or PRIT, in which immunoconjugates followed by radioligands are administered for treating tumors. This radioimmunotherapy reduces radiation doses to healthy tissues and utilizes radionuclides with very low half-lives incompatible with antibody-based vectors.
10:13
A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
0 Views •
Cited by 29 •
2015
Many types of human brain tumors are localized to specific regions within the brain and are difficult to grow in culture. This protocol addresses the role of tumor microenvironment and investigates new drug treatments by analyzing fluorescent primary brain tumor cells growing in an organotypic mouse brain slice.
FAQs
Researchers may estimate tumor target size from radiologic images, surgical specimens, or other validated measurements. The appropriate source depends on the study or clinical purpose, but the measurement must be obtained consistently enough to represent the tumor being evaluated. This provides a defensible basis for treatment planning, imaging interpretation, and comparisons between experimental groups.
Repeated measurements allow researchers to compare tumor growth or reduction across defined time points. Changes in dimension or volume can then contribute to judging whether an intervention reaches or controls its intended target. In cancer research, this temporal information supports response assessment and helps interpret whether observed physical tumor changes are consistent with the study’s objectives.
Model selection should reflect the target that researchers intend to treat, image, or analyze. Tumor target size supplies a measurable description of tumor burden that can help connect a selected model with the planned experimental question. This alignment supports more meaningful interpretation when investigators evaluate treatment effects, imaging findings, or changes in tumor growth.
The selected size measurement gives an endpoint a physical basis that can be examined across time or between study groups. Researchers can relate the reported dimension or volume to tumor burden and then interpret whether an intervention produces the expected change. This helps distinguish a measurement-based outcome from a conclusion that lacks a defined target.
First, researchers identify whether the measurement will guide treatment, imaging, or experimental analysis. They then obtain the size from radiologic images, a surgical specimen, or another validated source. After recording the dimension or volume, they apply it consistently to define a treatment field, compare groups, or track tumor behavior and response.
It is useful when investigators need to connect a tumor’s physical burden with a research or clinical decision. The measurement can guide treatment-field definition, support interpretation of study endpoints, and help evaluate whether an intervention reaches or controls its intended target. It also provides context for comparing groups and monitoring tumor growth or response.